These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. THE PROPHYLAXIS OF TETANUS. BETTMAN JW Am J Ophthalmol; 1963 Nov; 56():806-10. PubMed ID: 14077186 [No Abstract] [Full Text] [Related]
5. ACTIVE IMMUNIZATION AGAINST TETANUS: THE NEED FOR A SINGLE ALL-PURPOSE TOXOID. TRINCA JC Med J Aust; 1965 Jul; 2(3):116-20. PubMed ID: 14333768 [No Abstract] [Full Text] [Related]
6. [Tetanus vaccination in relation to the importance of protection by vaccination]. Bartelheimer HK; Mai K Monatsschr Kinderheilkd (1902); 1970 Sep; 118(9):558-60. PubMed ID: 5521671 [No Abstract] [Full Text] [Related]
7. [Hemorrhagic vasculitis as a manifestation of serum disease]. Okhrimovich LM; Pokin'chereda VV; Zhura II; Kulish VV Vrach Delo; 1980 Oct; (10):47-8. PubMed ID: 7434704 [No Abstract] [Full Text] [Related]
8. Tetanus prophylaxis. J Ir Med Assoc; 1968 Apr; 61(370):145-6. PubMed ID: 5656471 [No Abstract] [Full Text] [Related]
9. [Use of reduced doses of diphtheria-tetanus toxoid for revaccination of children with changed reactivity]. Braginskaia VP; Shabad AT; Manvelova MA; Aleksina SG; Podshivalova VA Vopr Okhr Materin Det; 1974 Feb; 19(2):65-9. PubMed ID: 4468507 [No Abstract] [Full Text] [Related]
10. Tetanus toxoid. Can Med Assoc J; 1968 Jan; 98(2):123. PubMed ID: 5635021 [No Abstract] [Full Text] [Related]
11. [Efficiency of reinforcing tetanus vaccination, prevention of hyperimmunizations]. Harrfeldt HP Monatsschr Unfallheilkd; 1975 Jan; 78(1):25-34. PubMed ID: 1124088 [No Abstract] [Full Text] [Related]
12. [Unusual course of a case of serum sickness following tetanus]. FISCHER W Osterr Z Kinderheilkd Kinderfuersorge; 1951; 6(2):211-4. PubMed ID: 14882749 [No Abstract] [Full Text] [Related]
13. Serum sickness. WHITFIELD M Br Med J; 1953 Jan; 1(4802):141. PubMed ID: 13009113 [No Abstract] [Full Text] [Related]
14. Serum-sickness and local reactions in tetanus prophylaxis; a study of 400 cases. MOYNIHAN NH Lancet; 1955 Aug; 269(6884):264-6. PubMed ID: 13243707 [No Abstract] [Full Text] [Related]
16. [The expediency and feasibility of abolishing the use of antitetanus serum for injuries in the Arkhangel'sk region]. Sergeeva TI; Iastrebov VV Zh Mikrobiol Epidemiol Immunobiol; 1975 Nov; (11):106-9. PubMed ID: 1221685 [TBL] [Abstract][Full Text] [Related]
17. [Tetanus antitoxin levels and reactions following tetanus vaccination]. Kuhlwein A; Bleyl A Hautarzt; 1985 Aug; 36(8):462-4. PubMed ID: 3899998 [TBL] [Abstract][Full Text] [Related]
18. [Serum sickness following tetanus anti-toxin injection with concomitant formation of specific blood group immune-antibodies]. HOLLANDER L; WORTMANN F Praxis; 1952 Nov; 41(48):1047-8. PubMed ID: 13026749 [No Abstract] [Full Text] [Related]
19. Diphtheria and tetanus toxoids. Smith JW Br Med Bull; 1969 May; 25(2):177-82. PubMed ID: 4918532 [No Abstract] [Full Text] [Related]
20. [Current status of tetanus prevention]. Stallkamp B; Häring R; Tung LC Dtsch Med Wochenschr; 1974 Dec; 99(50):2579-86. PubMed ID: 4615889 [No Abstract] [Full Text] [Related] [Next] [New Search]